Key Findings
The United States stem cell market is anticipated to register a CAGR of 7.59%, over the forecast period. The country’s market growth is mainly accredited to stem cell therapy as a prospective approach towards treating the novel coronavirus, the rising concentration on research and development, the enhanced healthcare infrastructure, and the growing number of rare and chronic conditions. The base year considered for the market study is 2020, and the forecast years are from 2021 to 2025.

Market Insights
According to the National Clinical Trial Registry (NCT), presently, there are nearly 639 registered non-recruiting as well as recruiting clinical trials in the United States. These trials are spread across diverse developmental phases associated with stem cell therapies, for different indications. Besides, this factor is primarily attributed to the country’s stem cell market growth, as the various phases depict positive results.
On the other hand, stem cell therapy is also considered a promising approach towards treating the COVID-19 outbreak. However, the research is still in its nascent and initial stage. For instance, Lineage Cell Therapeutics secured a grant of $5 million, in May 2020, from the California Institute for Regenerative Medicine (CIRM), supporting the use of VAC. It entails Lineage’s allogeneic dendritic cell therapy for developing a potential vaccine against the SARS-CoV-2, the virus that causes COVID-19. As a result, these factors are expected to augment the United States’ stem cell market growth.

Competitive Insights
The leading companies operating in the country’s market include, Corning Inc, Thermo Fisher Scientific Inc, GE Healthcare, Becton, Dickinson and Company (BD), Stemcell Technologies, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments